Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

US Supreme Court Extends Pause on Decision Narrowing Abortion Pill Access

The U.S. Supreme Court on Monday extended a pause on a ruling that would curb the abortion pill mifepristone from being ⁠prescribed through telemedicine and dispensed...

Treatment of Vulvodynia Differs by Race and Ethnicity

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.

Maternal Endometriosis Tied to Birth Defects

Endometriosis in mothers is associated with an increased risk for congenital anomalies in their infants.

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

The U.S. Supreme Court on Monday extended a pause on a ruling that would curb the abortion pill mifepristone from being ⁠prescribed through telemedicine and dispensed...

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.

Endometriosis in mothers is associated with an increased risk for congenital anomalies in their infants.

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

News All Time

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

The plea was unexpected

HHS Changing Its Tune on Contraceptive Access

Focus of Title X program shifting to "natural family planning" and encouragement of pregnancy

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in GTN

'Something Is Wrong': Don't Dismiss Pregnant Patients

Bias often shapes whose voices we prioritize and whose we question

Medical Board Sanctions Docs for Delayed Care That Led to Deaths of 2 Pregnant Women

Reproductive rights advocates said Texas board should do more

Advanced Ovarian Cancer Responds to Claudin-Targeted Drug in Preliminary Trial

Partial responses in half of patients with platinum-resistant disease, as crowded ADC list grows

Giving Flu, Pertussis Shots on the Same Day Likely Safe in Pregnancy

Pregnancy, birth, neonatal outcomes similar to when giving a single shot

Study on Maternal RSV Vaccine Flags Possible Risk, Calls for More Research

Analyses unable to rule out potential increase in pregnancy-associated hypertensive disorders

Kennedy Tangles With Lawmakers Over Vitamin K Shots, Vaccines for Newborns

"I've never been anti-vax," the health secretary said

More Granular Risk Score May Improve Maternal Morbidity Prediction

New maternal Prenatal Risk Index model weighs more factors based on severity of risk

Tumor DNA Clearance Before Breast Cancer Surgery Predicts Response, Metastasis Risk

Potential guidance for decisions about treatment escalation, de-escalation

FDA Staff Raises Concerns on Breast, Prostate Cancer Drug Applications

The Oncologic Drugs Advisory Committee will meet for the first time in 9 months

SCOTUS Sides With Anti-Abortion Center Raising 1st Amendment Fears About State Probe

Ruling does not resolve the underlying case

Understanding Treatment Strategies for HER2 Positive IHC3+ Metastatic Solid Tumors

Understanding Treatment Strategies for HER2 Positive IHC3+ Metastatic Solid Tumors

First-in-Class Vepdegestrant Approved in Advanced Breast Cancer

Oral agent in second-line more than doubled median PFS in patients with ESR1 mutations

FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy

Panelists conflicted about positive trial's ability to validate biomarker-guided switching

Recommended News For You

examining differences in the rates of breast reconstruction following mastectomies.

Chronic pain and poor sleep are troublesome bed partners.

New guidelines for radiation therapy for HPV-associated head and neck cancer

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

The way that miR-377 inhibits cells that cause prostate cancer.

How 7,000 steps a day could help reduce your risk of cancer

Recommended Articles For You

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia 

Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

4.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

5.

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

1.

Angina Haemorrhagica Bullosa: What You Need to Know

2.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

3.

Exploring the Role of Fecal Leukocytes in Intestinal Health

4.

Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies

5.

HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part X

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

4.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot